Download PDF
Thromb Haemost 2013; 110(03): 396-398
DOI: 10.1160/TH13-07-0583
Theme Issue Editorial
Schattauer GmbH

The kallikreins: old proteases with new clinical potentials

Manfred Schmitt
1   Clinical Research Unit, Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany
,
Thomas Renné
2   Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden
3   Division of Clinical Chemistry, University Hospital Eppendorf, Hamburg, Germany;
,
Andreas Scorilas
4   Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece
› Author Affiliations
Further Information

Publication History

Received: 19 July 2013

Accepted: 19 July 2013

Publication Date:
22 November 2017 (online)

    Permissions and Reprints
 

  • References

  • 1 Schmitt M, Magdolen V. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers. Thromb Haemost 2009; 101: 222-224.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 04: 876-890.
    CrossrefPubMedGoogle Scholar
  • 3 Clements JA. Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?. Biol Chem 2008; 389: 1447-1454.
    CrossrefPubMedGoogle Scholar
  • 4 Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin Chem Lab Med 2012; 50: 1877-1891.
    CrossrefPubMedGoogle Scholar
  • 5 Lundwall A. Old genes and new genes: The evolution of the kallikrein locus. Thromb Haemost 2013; 110: 469-475.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection?. Annu Rev Med 2012; 63: 161-170.
    CrossrefPubMedGoogle Scholar
  • 7 Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432.
    CrossrefPubMedGoogle Scholar
  • 8 Pathak M, Wong SS, Dreveny I. et al. Structure of plasma and tissue kallikreins. Thromb Haemost 2013; 110: 423-433.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Ekholm IE, Brattsand M, Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J Invest Dermatol 2000; 114: 56-63.
    CrossrefPubMedGoogle Scholar
  • 10 Fischer J, Meyer-Hoffert U. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options. Thromb Haemost 2013; 110: 442-449.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Sotiropoulou G, Pampalakis G. Targeting the kallikrein-related peptidases for drug development. Trends Pharmacol Sci 2012; 33: 623-634.
    CrossrefPubMedGoogle Scholar
  • 12 Kontos CK, Mavridis K, Talieri M. et al. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects. Thromb Haemost 2013; 110: 450-457.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Dorn J, Bayani J, Yousef GM. et al. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thromb Haemost 2013; 110: 408-422.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Thorek DLJ, Evans MJ, Carlsson SV. et al. Prostate specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Thromb Haemost 2013; 110: 484-492.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Waeckel L, Potier L, Richer C. et al. Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost 2013; 110: 476-483.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Fink E, Bhoola KD, Snyman C. et al. Cellular expression of plasma prekallikrein in human tissues. Biol Chem 2007; 388: 957-963.
    CrossrefPubMedGoogle Scholar
  • 17 Marcondes S, Antunes E. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents 2005; 03: 33-44.
    CrossrefPubMedGoogle Scholar
  • 18 Björkqvist J, Jämsä A, Renné T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 2013; 110: 399-407.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Feener EP, Zhou Q, Fickweiler W. Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost 2013; 110: 434-441.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Pruneau D, Belichard P, Sahel JA. et al. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs 2010; 11: 507-514.
    PubMedGoogle Scholar
  • 21 de Maat S, van Dooremalen S, de Groot PG. et al. A nanobody-based method for tracking factor XII activation in plasma. Thromb Haemost 2013; 110: 458-468.
    Article in Thieme ConnectPubMedGoogle Scholar